In This Article:
Online pet retailer Chewy (NYSE: CHWY) enjoyed a period of skyrocketing pet ownership during the pandemic. Revenue soared 24% in 2021 as pet owners turned to Chewy for its attractive prices and convenient shipping options. The stock soared as well, peaking at around $120 per share in early 2021.
The bill is now coming due. Demand was pulled forward by the pandemic, with new pet households forming that otherwise would have remained pet-free or delayed getting a pet. Even as it wins market share, Chewy is struggling to retain its customer base.
Sluggish growth
Chewy managed to grow revenue by 4.2% in the fourth quarter of 2023 thanks to heavier spending from its active customers, but the number of active customers declined. Chewy ended the year with 20.1 million active customers, down from 20.7 million at the end of 2021 and down 1.6% year over year.
Chewy is profitable, but just barely. The company managed a net income margin of just 1.1% in the fourth quarter, and that was largely due to interest income on the mountain of cash it keeps on its balance sheet. On an operating basis, Chewy reported a loss for both the fourth quarter and the full year.
While Chewy expects pet industry trends to revert to historical norms in 2025, this year will be another tough one for the company. Chewy expects pet household formation to remain muted. The company also doesn't anticipate a tailwind from higher pricing.
Chewy is working to cut costs and become more efficient, but the core retail business is inherently a low-margin affair. Chewy's gross margin was just 28.4% in 2023. When it comes to things like dog food that pet owners must buy over and over again, price is a big factor, and competition is fierce.
A critical growth initiative
According to a report from the American Veterinary Medical Association, the most important determining factor for pet owners choosing a vet is expertise. The smallest factor is price. The situation is flipped when it comes to buying medication, either online or in-store.
Chewy already operates a pet pharmacy business, but that business is subject to the same price sensitivity as the core retail business. While the pet pharmacy unlocks an additional market for Chewy, it likely won't help much to boost the company's margins.
What could help is Chewy's recent foray into the vet clinic business. Chewy sees a $25 billion opportunity in veterinary care. Importantly, the company expects the vet care business to have meaningfully higher margins than the company as a whole.
Chewy will start slow. The first vet clinic is set to open soon, and the company could open as many as eight clinics in fiscal 2024. If these early clinics perform well, the company has the potential to open a large number of locations across the United States in the coming years.